Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended 6 Months Ended 128 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
COSTS AND EXPENSES:          
Research and development $ 1,648,838 $ 1,314,623 $ 3,239,450 $ 2,642,937 $ 29,167,175
General and administrative 1,073,749 896,881 2,195,452 1,894,552 15,490,162
Merger costs 0 0 0 0 799,133
Total costs and expenses 2,722,587 2,211,504 5,434,902 4,537,489 45,456,470
LOSS FROM OPERATIONS (2,722,587) (2,211,504) (5,434,902) (4,537,489) (45,456,470)
OTHER INCOME (EXPENSE):          
Grant income 0 0 0 0 244,479
Gain (loss) on revaluation of derivative warrants 660,341 (17,234) 666,384 (46,080) 620,372
Loss on issuance of derivative warrants 0 0 (744,957) 0 (744,957)
Interest expense, net (2,216) (2,073) (4,866) (4,145) (460,326)
Other income 0 0 0 0 1,161
Total other income (expense), net 658,125 (19,307) (83,439) (50,225) (339,271)
NET LOSS (2,064,462) (2,230,811) (5,518,341) (4,587,714) (45,795,741)
DEEMED DIVIDEND ON WARRANTS 0 0 0 0 (543,359)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,064,462) $ (2,230,811) $ (5,518,341) $ (4,587,714) $ (46,339,100)
BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE (in dollars per share) $ (0.04) $ (0.06) $ (0.10) $ (0.12) $ (2.91)
SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE (in shares) 57,397,997 38,598,586 54,359,323 37,754,402 15,917,857